Analysen von Michael Leuchten
| 14.06.18 | GSK buy | UBS AG | |
| 14.06.18 | Novo Nordisk buy | UBS AG | |
| 08.06.18 | Novo Nordisk buy | UBS AG | |
| 06.06.18 | Bayer buy | UBS AG | |
| 31.05.18 | Bayer buy | UBS AG | |
| 30.05.18 | Novo Nordisk buy | UBS AG | |
| 30.05.18 | Bayer buy | UBS AG | |
| 25.05.18 | GSK buy | UBS AG | |
|
Werbung
|
|||
| 17.05.18 | Merck buy | UBS AG | |
| 15.05.18 | Merck buy | UBS AG | |
| 03.05.18 | Bayer buy | UBS AG | |
| 03.05.18 | Novo Nordisk buy | UBS AG | |
| 02.05.18 | Novo Nordisk buy | UBS AG | |
| 27.04.18 | Novartis Neutral | UBS AG | |
| 26.04.18 | GSK buy | UBS AG | |
| 25.04.18 | Novo Nordisk buy | UBS AG | |
| 19.04.18 | Novartis Neutral | UBS AG | |
| 09.04.18 | Novartis Neutral | UBS AG | |
| 05.04.18 | GSK buy | UBS AG | |
| 04.04.18 | Merck Buy | UBS AG | |
| 27.03.18 | Novartis Neutral | UBS AG | |
| 27.03.18 | GSK buy | UBS AG | |
| 27.03.18 | Novo Nordisk buy | UBS AG | |
| 22.03.18 | Bayer buy | UBS AG | |
| 12.03.18 | Merck buy | UBS AG | |
| 08.03.18 | Merck buy | UBS AG | |
| 01.03.18 | Novartis Neutral | UBS AG | |
| 28.02.18 | Bayer buy | UBS AG | |
| 19.02.18 | Novo Nordisk buy | UBS AG | |
| 16.02.18 | Merck buy | UBS AG | |
| 14.02.18 | Bayer buy | UBS AG | |
| 12.02.18 | Bayer buy | UBS AG | |
| 08.02.18 | GSK buy | UBS AG | |
| 07.02.18 | Novo Nordisk buy | UBS AG | |
| 02.02.18 | Novo Nordisk buy | UBS AG | |
| 01.02.18 | Novo Nordisk buy | UBS AG | |
| 15.01.18 | Sanofi Neutral | UBS AG | |
| 15.01.18 | Roche Neutral | UBS AG | |
| 15.01.18 | Novo Nordisk buy | UBS AG | |
| 15.01.18 | Novartis Neutral | UBS AG | |
| 15.01.18 | Merck buy | UBS AG | |
| 15.01.18 | GSK buy | UBS AG | |
| 15.01.18 | Bayer buy | UBS AG | |
| 15.01.18 | AstraZeneca Neutral | UBS AG | |
| 12.01.18 | Novo Nordisk buy | UBS AG | |
| 08.01.18 | Novo Nordisk buy | UBS AG | |
| 13.12.17 | GSK buy | UBS AG | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |